This Activity Requires You To Leave myCME.

You are now leaving myCME and connecting to our educational partner. myCME does not control content, practices, or other policies of the site you are entering.

You are about to open a webpage that is outside of this educational content.

  • Overview
This CME Activity has expired and is no longer available for credit.
Women and Depression: Navigating the Clinical Course

Women and Depression: Navigating the Clinical Course


Patient Case Simulations

Time to Complete

1 hour


November 1, 2012


October 31, 2013

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

Sponsored by the Texas Health Research & Education Institute

Commercial Supporter

This activity is supported by an educational grant from Pfizer Inc.

Program Description

Lissette Arnott©, a CME-certified case-based branched learning game, is provided by Texas Health Research & Education Institute to improve outcomes for women with depression in the primary care setting. The interactive and immersive 3D virtual learning environment provides concise information on depression management and helps you sharpen decision-making and critical-thinking skills to apply to your patients immediately. Branch out today into this dynamic, online simulated world.

Intended Audience

This online educational enduring material is designed for primary care physicians, psychiatrists, physician assistants, and nurse practitioners. Its purpose is to address the need for screening, recognizing, and treating major depression in women.

Educational Objectives

At the end of this online enduring material, participants should be able to:

  • Demonstrate how objective and subjective complexity indicators can be used for MDD care in women
  • Show the importance of developing individualized treatment plans for MDD patients that are driven by data, evidence-based guidelines, and patient input
  • Manage MDD patients with a broad range of treatment strategies
  • Emphasize a collaborative multidisciplinary approach to patient management

Disclosure of Conflicts of Interest

In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, Texas Health Research & Education Institute requires that all faculty and planning committee members disclose financial relationships relevant to the content being planned and/or presented. The relevant financial relationships are those they may have with any commercial interest producing health care goods or services consumed by or used on patients. Disclosures are provided below for the CME activity chair, planners and content reviewer.


Leslie Secrest, MD – Chair
Texas Health Presbyterian Hospital Dallas*
Dallas, TX

*Doctors on the medical staff practice independently and are not employees or agents of the hospital except resident doctors in the hospital’s graduate medical education program.

Dr. Secrest has no relevant financial relationship with proprietary entities producing health care goods or services related to the content of this CME activity.

Planning Committee
Scott Dahl, MBA, BS
Mary Digison, RN
Christina Martin
Marilyn Peterson, MA, CCMEP
Sandra Pinkerton, PhD, CCMEP
Gwen Pond
Elizabeth Weidmer-Mikhail, MD

The planners have no relevant financial relationship with proprietary entities producing health care goods or services related to the content of this CME activity.

Content Reviewer
Madhukar Trivedi, MD

Betty Jo Hay Distinguished Chair in Mental Health
Professor, Department of Psychiatry
University of Texas Southwestern Medical Center
Dallas, TX

Dr. Trivedi, has disclosed the following relevant financial relationships with proprietary entities producing health care goods or services related to the content of this CME activity:
Receives consulting fees from Abbott Laboratories, Inc., Alkermes, AstraZeneca, Axon Advisors, Bristol-Myers Squibb Company, Cephalon, Inc., Eli Lilly & Company, Evotek, Forest Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson PRD, Lundbeck, MedAvante, Neuronetics, Otsuka Pharmaceuticals, Pamlab, Pfizer, Inc., PgxHealth, Rexahn Pharmaceuticals, SHIRE Development, Takeda, Tal Medical/Puretech Venture, and Transcept.
Receives research support from Agency for Healthcare Research and Quality, National Institute of Mental Health, National Institute on Drug Abuse, Naurex, Targacept, and Valient.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Texas Health Research & Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Texas Health Research & Education Institute designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


For full program information, please click on “BEGIN” button and follow the next click-through to reach this program site. Once you get to the “Texas Health Research & Education Institute” description page, you will review program information, program content, take the test, and receive credit.

If you have any questions relating to the accreditation or your certificate for this activity, please contact us at 866-295-3269, ext 1.

Privacy Policy

Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Add to Queue